GLP-1 receptor agonists have also shown success in other therapeutic areas apart from type 2 diabetes and obesity, in particular for non-alcoholic fatty liver disease [104]
[11] The risk here isnt usually lack of efficacy
In developed countries, excessive calorie intake and frequent consumption of unhealthy foods, associated with a sedentary lifestyle, have caused an increase in the prevalence of obesity, which in turn predisposes to several non-communicable diseases, such as cardiovascular disease, diabetes, hypertension, and chronic kidney disease [9]
The second dimension is biologic format preference for new development programs
It typically includes doctor consultations, necessary lab work, access to prescribed medications (if eligible), unlimited support, and comprehensive guidance on nutrition, exercise, and lifestyle
Serious adverse events were balanced across groups